BeStock  
Markets › Compare › GLAPY vs SUPN

GLAPY vs SUPN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
GLAPY · GLANBIA SPONS ADR EACH REP 5 COM EUR0.06$110.93 ▲ 0.00%
SUPN · Supernus Pharmaceuticals$28.61 ▲ 0.92%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5182113144175Nov 24, '25May 26, '26Nov 20, '26
  • GLAPY +31.4%
  • SUPN -36.6%

Head to head

MetricGLAPYSUPN
Price$110.93$28.61
Change today▲ 0.00%▲ 0.92%
Market cap$5.95B$5.94B
Return, 3 months-12.7%-36.6%
Return, year to date+31.4%-42.4%
Return, 1 year+31.4%-36.9%
P/E (TTM)22.9–
P/B2.85.6
P/E percentile vs own 5y–20th
Dividend yield2.31%–
Revenue growth (YoY, latest qtr)–+18.0%
Net profit growth (YoY)–+146.4%
Gross margin–87.6%
Operating margin–3.2%
Net margin–-5.1%
Return on equity–-4.2%
Analyst target vs. price–+83.9%
Analyst buy share–83%
RSI (14)3236
30-day volatility35.6%127.6%
Max drawdown, 1 year-23.8%-53.6%
Trend readStrong downtrendStrong downtrend
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • GLAPY is the largest of the group by market value.
  • GLAPY has returned the most over the past year.
  • GLAPY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top